BackGossamer Bio Overview
Gossamer Bio Inc

Gossamer Bio Target Price

Where could GOSS trade next? Consensus target price: $32.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.27

Average Target Price

$32.00184.1% upside

1 analysts in the last 4 months

High: $32 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-11WedbushLaura Chicho$32184.1% upsideOpen
2026-02-24Wedbush$191.1% downsideOpen
2026-02-24BarclaysEliana Merle$0.397.3% downsideOpen
2026-02-24Leerink Partners$191.1% downsideOpen
2026-01-27Barclays$920.1% downsideOpen
2025-09-10UBS$920.1% downsideOpen
2022-12-08H.C. Wainwright$555.6% downsideOpen
2022-12-07Barclays$282.2% downsideOpen
2022-12-07Raymond James$555.6% downsideOpen
2022-12-06SMBC NikkoDavid Hoang$373.4% downsideOpen
2022-04-26Barclays$126.5% upsideOpen
2022-04-26Raymond James$1011.2% downsideOpen

Gossamer Bio (GOSS) FAQ

Gossamer Bio (GOSS) currently reports a target price of $32. Use the charts on this page to explore Gossamer Bio's target price history and peer comparisons.

Analysts' average 12-month price target for Gossamer Bio is $32, about 184.1% upside from the current share price of $11.27. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $32, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gossamer Bio, and consider following GOSS for alerts when major investors trade the stock.

Gossamer Bio is classified in the Healthcare sector. On target price, it currently shows $32. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GOSS with unrelated industries.